Frequently Asked Questions
North America is dominating the patau syndrome market in the forecast period due to the presence of key manufacturers.
The growth rate of the patau syndrome market is 25% in the forecast period by 2029.
Major companies in the patau syndrome market are Centogene N.V. (Germany), Eurofins Discovery (Luxembourg), Hoffmann-La Roche Ltd. (Switzerland), Invitae Corporation (U.S.), LLumina Inc (U.S.), Natera Inc (U.S.), PerkinElmer Inc (U.S.), Quest Diagnostics Incorporated (U.S.), Eurofins LifeCodexx GmbH (Germany), Ravgen (U.S.).
Treatment, diagnosis, distribution channel, and end-user are the factors on which the patau syndrome market research is based.
The increasing prevalence of patau syndrome & increase in the number of research and development activities are the growth drivers of the patau syndrome market.
